KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Amithraz Balgobin, 36, allegedly attacked Amaratial Mistry at a property in Streatham, south London, on Friday July 4.

A missing elderly woman with dementia has been found deceased in Daviess County. Lola Davis, 89, of Mt. Vernon, Indiana, went ...